Editas Medicine, Inc. IPO Research Information

Editas Medicine, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Editas Medicine, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Editas Medicine, Inc.	EDIT - NASDAQ	$16.00-$18.00	$16.00	$18.00	5.9 million	2/3/2016
Underwriter(s): Morgan Stanley, J.P. Morgan
Co-Manager(s): Cowen and Company, JMP Securities
Industry: Health Care
Filing(s): Filed 2016-01-04 Terms Added 2016-01-24

Editas Medicine, Inc. Quote & Chart - Click for current quote - EDIT

About Editas Medicine, Inc. (adapted from Editas Medicine, Inc. prospectus):
They are a leading genome editing company dedicated to treating patients with genetically defined diseases by correcting their disease-causing genes.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "EDIT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.